Record patient and surgical volumes, double-digit revenue and net income growth, and strong expansion in both hospital and insurance segments marked the quarter. Leverage improved, investments accelerated, and ESG initiatives advanced, with the share price up 68.4% YTD.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.